Stem Cells

  • Read more: DUE 6/3: Call for Abstracts: Emerging Issues and New Frontiers for FDA Regulation

    DUE 6/3: Call for Abstracts: Emerging Issues and New Frontiers for FDA Regulation

                                     The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to announce an upcoming collaborative academic symposium: Emerging Issues and New Frontiers for FDA Regulation Monday, October 20, 2014  Washington, DC…

  • Read more: Call for Abstracts: Emerging Issues and New Frontiers for FDA Regulation

    Call for Abstracts: Emerging Issues and New Frontiers for FDA Regulation

          The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to announce an upcoming collaborative academic symposium: Emerging Issues and New Frontiers for FDA Regulation Monday, October 20, 2014  Washington, DC We are currently seeking abstracts for academic presentations/papers…

  • Read more: TOMORROW: Hot Topics in European Bio-Patent Law: Stem Cells, Genes, and More

    TOMORROW: Hot Topics in European Bio-Patent Law: Stem Cells, Genes, and More

    Hot Topics in European Bio-Patent Law: Stem Cells, Genes, and More April 2, 2014, 12:00 PM Langdell, Vorenberg Classroom – North (225), Harvard Law School, Cambridge, MA Please join us for this esteemed panel of leading patent experts, including members of the European Patent Office. Discussion will address U.S. and European perspectives on patenting stem cells, genes,…

  • Read more: 4/2: Hot Topics in European Bio-Patent Law: Stem Cells, Genes, and More

    4/2: Hot Topics in European Bio-Patent Law: Stem Cells, Genes, and More

    Hot Topics in European Bio-Patent Law: Stem Cells, Genes, and More April 2, 2014, 12:00 PM Langdell, Vorenberg Classroom – North (225), Harvard Law School, Cambridge, MA Please join us for this esteemed panel of leading patent experts, including members of the European Patent Office. Discussion will address U.S. and European perspectives on patenting stem cells, genes,…

  • Read more: An interview with I. Glenn Cohen on law and bioscience

    An interview with I. Glenn Cohen on law and bioscience

    With the first issue of Journal of Law and Biosciences now available, the Oxford University Press blog has published an interview with I. Glenn Cohen discussing the journal’s focus and format. From the blog: There are huge changes taking place in the world of biosciences, and whether it’s new discoveries in stem cell research, new…

  • Read more: TOMORROW: Frances Kamm’s Bioethical Prescriptions: Book Talk and Panel Discussion

    TOMORROW: Frances Kamm’s Bioethical Prescriptions: Book Talk and Panel Discussion

    Please join us on February 27 at 2:00pm in Wasserstein 1019 at the Harvard Law School as we launch Professor Frances Kamm’s latest book, Bioethical Prescriptions: To Create, End, Choose, and Improve Lives (Oxford University Press, January 2014). The book showcases Professor Kamm’s articles on bioethics as parts of a coherent whole, with sections devoted to death and dying; early…

  • Read more: 2/27: Frances Kamm’s Bioethical Prescriptions: Book Talk and Panel Discussion

    2/27: Frances Kamm’s Bioethical Prescriptions: Book Talk and Panel Discussion

    Please join us on February 27 at 2:00pm in Wasserstein 1019 at the Harvard Law School as we launch Professor Frances Kamm’s latest book, Bioethical Prescriptions: To Create, End, Choose, and Improve Lives (Oxford University Press, January 2014). The book showcases Professor Kamm’s articles on bioethics as parts of a coherent whole, with sections devoted…

  • Read more: DC Circuit Upholds FDA Authority Over Stem Cells

    DC Circuit Upholds FDA Authority Over Stem Cells

    Earlier this week, the D.C. Circuit upheld the FDA’s authority to regulate stem cells (for a good news report see here). The company in question, Regenerative Sciences, had received a warning letter from FDA, which the company challenged claiming that its use of stem cells as therapy was not prohibited by existing federal law and that…

  • Read more: Technological Solutions to Moral Problems

    Technological Solutions to Moral Problems

    By Matthew L Baum When we consider our society’s tough moral questions, like whether it is acceptable to use embryonic stem cells for research and medicine, we often look towards governmental leaders, policy makers, lawyers, and ethicists to find solutions. But should we look more often towards engineers? This week in Nature, a research group…

  • Read more: TOMORROW: Second Annual Health Law Year in P/Review

    TOMORROW: Second Annual Health Law Year in P/Review

    Please join us for our second annual Health Law Year in P/Review event, co-sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the New England Journal of Medicine. The conference will be held in Wasserstein Hall, Milstein East C at Harvard Law School on Friday, January 31, 2014, from 8:30am to 5:00pm. This year we will…